Milestone Pharmaceuticals Inc. Prepaid Expense, Current
Milestone Pharmaceuticals Inc. (MIST) had Prepaid Expense, Current of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense, Current $1.03M.
- 2026-03-31: Prepaid Expense, Current $1.21M.
- 2025-12-31: Prepaid Expense, Current $1.80M.
- 2025-09-30: Prepaid Expense, Current $2.58M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.80M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $748.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.36M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.84M 10-K · filed 2026-03-20 |
| 2024-09-30 | $2.52M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.71M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.36M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.18M 10-K · filed 2025-03-13 |
| 2023-09-30 | $6.96M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.40M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.45M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.00M 10-K · filed 2024-03-21 |
| 2022-09-30 | $5.06M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.46M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $4.07M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.30M 10-K · filed 2023-03-29 |
| 2021-09-30 | $5.97M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $7.45M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $6.29M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $5.43M 10-K · filed 2022-03-24 |
| 2020-09-30 | $3.50M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $6.13M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.56M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.84M 10-K · filed 2021-03-29 |
| 2019-09-30 | $3.52M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $5.03M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $5.48M 10-Q · filed 2019-06-19 |
| 2018-12-31 | $1.40M 10-K/A · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |